Christopher Gerry is listed as an executive officer and director on 1 SEC Form D filing by 1 issuer in Mar 2026: Sensei Biotherapeutics, Inc. (Rockville, MD — biotechnology — 2026; $348.9M reported sold to 104 investors).
What this means One deal on file with the SEC, filed Mar 2026. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Anand Kiran Parikh (1 shared filing), Bob Holmen (1 shared filing), Josiah Craver (1 shared filing), Kristian Humer (1 shared filing), Phillip B. Donenberg (1 shared filing) and 1 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Christopher. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 2 bankruptcy cases matching the name listed in Key records below.
What this means 2 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 1 public filing for Christopher Gerry and found 2 differences, 2 worth asking the sponsor about: Bankruptcy case: Laura E Gerry and Christopher M Gerry; Bankruptcy case: Christopher L. Gerry and Kathleen R. Gerry.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.